Each 10 ml contains Calcium gluconate (monohydrate) 0.958 g equivalent to Calcium gluconate (anhydrous) 0.9195 g, Calcium saccharate 0.035 g.
Each 1 ml contains Calcium gluconate equivalent to 0.45 mEq. of Calcium ion.
Treatment of acute hypocalcemic tetany secondary to renal failure, hypoparathyroidism, premature delivery, poisoning with magnesium, and prevention of hypocalcemia during exchange transfusions.
Treatment of electrolyte depletion.
Used with ECG monitoring, to decrease the cardiac depressant effects of hyperkalemia on ECG function.
The injection should be warmed to body temperature prior to administration and slowly injected. Following injection, the patient should remain recumbent for a short period of time to prevent dizziness.
Adults: Antihypocalcemic or Electrolyte replenisher: IV, 10-30 ml administered slowly at a rate not exceeding 2-5 ml/minute. The dosage may be repeated, if necessary, until tetany is controlled.
Antihyperkalemic: IV, 5-30 ml administered slowly at a rate not exceeding 2-5 ml/minute. The dosage should be titrated and adjusted by constant monitoring of ECG changes during administration.
Children: Antihypocalcemic: IV, 2-15 ml as a single dose, administered slowly at a rate not exceeding 2-5 ml/minute, repeated if necessary until tetany is controlled.
Exchange transfusions in newborns: IV, 1 ml administered after every 100 ml of citrated blood exchanged.
It is contraindicated in patients with digitalis toxicity, cardiac function impairment, ventricular fibrillation, or hypercalcemia.
Calcium gluconate injection is usually administered intravenously, intramuscular, intramyocardial, or subcutaneous administration may cause burning, severe tissue necrosis, and sloughing, or abscess formation.
It should be used with caution in patients with sarcoidosis, renal disease, and in patients receiving cardiac glycosides.
The drug should not be mixed with tetracycline antibiotic, carbonates, bicarbonates, phosphates, sulfates, or tartrates, since it may cause incompatibility.
Hypotension (dizziness); flushing and/or sensation of warmth or heat; irregular heartbeat; nausea or vomiting; skin redness, rash, pain, or burning at injection site- are most frequent side effects.
Tingling sensation or hypotension may result when IV injection is too rapid.
A12AA03 - calcium gluconate ; Belongs to the class of calcium-containing preparations. Used as dietary supplements.
Inj (amp) 0.45 mEq/10 mL x 50 x 1's.